Municipal Employees Retirement System of Michigan Buys 78,820 Shares of AngioDynamics, Inc. (ANGO)
Municipal Employees Retirement System of Michigan raised its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 965.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 86,980 shares of the medical instruments supplier’s stock after acquiring an additional 78,820 shares during the quarter. Municipal Employees Retirement System of Michigan owned approximately 0.24% of AngioDynamics worth $1,486,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. State of Alaska Department of Revenue lifted its holdings in shares of AngioDynamics by 91.7% during the 2nd quarter. State of Alaska Department of Revenue now owns 6,768 shares of the medical instruments supplier’s stock valued at $109,000 after purchasing an additional 3,238 shares during the last quarter. Teachers Retirement System of The State of Kentucky lifted its holdings in shares of AngioDynamics by 77.5% during the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock valued at $123,000 after purchasing an additional 3,100 shares during the last quarter. Acrospire Investment Management LLC lifted its holdings in shares of AngioDynamics by 3.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 8,915 shares of the medical instruments supplier’s stock valued at $145,000 after purchasing an additional 317 shares during the last quarter. UBS Asset Management Americas Inc. purchased a new stake in shares of AngioDynamics during the 1st quarter valued at $191,000. Finally, Louisiana State Employees Retirement System lifted its holdings in shares of AngioDynamics by 6.9% during the 2nd quarter. Louisiana State Employees Retirement System now owns 13,900 shares of the medical instruments supplier’s stock valued at $225,000 after purchasing an additional 900 shares during the last quarter. 96.06% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/18/municipal-employees-retirement-system-of-michigan-buys-78820-shares-of-angiodynamics-inc-ango.html.
AngioDynamics, Inc. (NASDAQ:ANGO) opened at $17.00 on Friday. The stock has a market capitalization of $624.17, a price-to-earnings ratio of 24.43, a P/E/G ratio of 1.73 and a beta of 1.05. The company has a debt-to-equity ratio of 0.17, a current ratio of 2.34 and a quick ratio of 1.48. AngioDynamics, Inc. has a 52 week low of $14.80 and a 52 week high of $18.85.
AngioDynamics (NASDAQ:ANGO) last issued its earnings results on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.16 by ($0.04). The firm had revenue of $85.40 million during the quarter, compared to analysts’ expectations of $86.12 million. AngioDynamics had a return on equity of 4.83% and a net margin of 1.64%. The business’s revenue was down 3.1% on a year-over-year basis. During the same quarter last year, the business earned $0.17 EPS. analysts forecast that AngioDynamics, Inc. will post 0.65 earnings per share for the current fiscal year.
Several analysts have recently commented on ANGO shares. Zacks Investment Research upgraded AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective for the company in a report on Tuesday, October 3rd. Canaccord Genuity reiterated a “hold” rating and set a $17.00 price objective on shares of AngioDynamics in a report on Sunday, October 8th. KeyCorp reiterated a “hold” rating on shares of AngioDynamics in a report on Friday, September 29th. Finally, BidaskClub upgraded AngioDynamics from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $18.60.
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).
Receive News & Stock Ratings for AngioDynamics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics Inc. and related stocks with our FREE daily email newsletter.